GENEVA, Feb. 11 -- LAPKO INC, DBA AFECTA PHARMACEUTICALS (4730 S. Fort Apache RoadLas Vegas, Nevada 89147) filed a patent application (PCT/US2025/039964) for "INHIBITION OF GLIAL CELL ACTIVATION" on Jul 30, 2025. With publication no. WO/2026/030500, the details related to the patent application was published on Feb 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KOVACS, Bruce (2102 Business Center DriveIrvine, California 92612)
Abstract: Compounds and methods useful for inhibition of glial cell activation and for the treatment of diseases associated with increased glial cell activation ...